Antagonization of neuromuscular blockade by sugammadex vs. neostigmine in patients undergoing robotic-assisted urological procedures - effect on extubation time and quality of the recovery - monocentric prospective randomized study

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F44555601%3A13450%2F21%3A43896871" target="_blank" >RIV/44555601:13450/21:43896871 - isvavai.cz</a>

Výsledek na webu

<a href="https://aimjournal.cz/artkey/aim-202104-0001_antagonization-of-neuromuscular-blockade-by-sugammadex-vs-neostigmine-in-patients-undergoing-robotic-8209-ass.php" target="_blank" >https://aimjournal.cz/artkey/aim-202104-0001_antagonization-of-neuromuscular-blockade-by-sugammadex-vs-neostigmine-in-patients-undergoing-robotic-8209-ass.php</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.36290/aim.2021.047" target="_blank" >10.36290/aim.2021.047</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Antagonization of neuromuscular blockade by sugammadex vs. neostigmine in patients undergoing robotic-assisted urological procedures - effect on extubation time and quality of the recovery - monocentric prospective randomized study

Popis výsledku v původním jazyce

Objective: The aim of the study was to test the hypothesis that the use of sugammadex shortens the time to extubation compared to the use of neostigmine in patients undergoing robotically assisted urological procedures. Design: Monocentric prospective randomized study. Setting: Tertiary Care Hospital. Material and methods: Sixty adult patients undergoing robotic-assisted urological laparoscopic surgery without contrain-dications to the administration of rocuronium, neostigmine and sugammadex, with perioperative monitoring of the depth of neuromuscular blockade. Patients were randomized to the group with antagonization of the neuromuscular blockade with either neostigmine or sugammadex. Primary outcome was time to extubation from injection of the antagonist. Results: Sixty-one patients with ASA I-III were enrolled. The time to extubation was significantly shorter in the sugammadex group compared to neostigmine group: 10; 3.5-35 minutes, 45; 16-88 minutes respectively, p &lt; 0.00001 (data shown as an average; minimum - maximum range). In addition, patients in the sugammadex group were transported significantly faster from the operating room. There were no differences in the quality and rate of recovery in 72 hours postoperatively. Conclusion: Sugammadex statistically significantly accelerated the time from administration to extubation in ASA I-III patients after robotic-assisted urologic laparoscopic surgery compared to neostigmine. Thus, sugammadex significantly accelerated the patients&apos; operating room turn-over time.

Název v anglickém jazyce

Antagonization of neuromuscular blockade by sugammadex vs. neostigmine in patients undergoing robotic-assisted urological procedures - effect on extubation time and quality of the recovery - monocentric prospective randomized study

Popis výsledku anglicky

Objective: The aim of the study was to test the hypothesis that the use of sugammadex shortens the time to extubation compared to the use of neostigmine in patients undergoing robotically assisted urological procedures. Design: Monocentric prospective randomized study. Setting: Tertiary Care Hospital. Material and methods: Sixty adult patients undergoing robotic-assisted urological laparoscopic surgery without contrain-dications to the administration of rocuronium, neostigmine and sugammadex, with perioperative monitoring of the depth of neuromuscular blockade. Patients were randomized to the group with antagonization of the neuromuscular blockade with either neostigmine or sugammadex. Primary outcome was time to extubation from injection of the antagonist. Results: Sixty-one patients with ASA I-III were enrolled. The time to extubation was significantly shorter in the sugammadex group compared to neostigmine group: 10; 3.5-35 minutes, 45; 16-88 minutes respectively, p &lt; 0.00001 (data shown as an average; minimum - maximum range). In addition, patients in the sugammadex group were transported significantly faster from the operating room. There were no differences in the quality and rate of recovery in 72 hours postoperatively. Conclusion: Sugammadex statistically significantly accelerated the time from administration to extubation in ASA I-III patients after robotic-assisted urologic laparoscopic surgery compared to neostigmine. Thus, sugammadex significantly accelerated the patients&apos; operating room turn-over time.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30223 - Anaesthesiology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Anesteziologie a intenzivní medicína

ISSN

1214-2158

e-ISSN

—

Svazek periodika

32

Číslo periodika v rámci svazku

4-5

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

6

Strana od-do

191-196

Kód UT WoS článku

000751668600001

EID výsledku v databázi Scopus

—